CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $283,079 | +109.3% | 7,368 | +26.1% | 0.00% | 0.0% |
Q1 2023 | $135,219 | -18.4% | 5,841 | -7.7% | 0.00% | 0.0% |
Q4 2022 | $165,715 | -1.9% | 6,325 | -26.3% | 0.00% | 0.0% |
Q3 2022 | $169,000 | +445.2% | 8,583 | +391.3% | 0.00% | – |
Q2 2022 | $31,000 | 0.0% | 1,747 | -9.2% | 0.00% | – |
Q1 2022 | $31,000 | – | 1,923 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 14,158 | $12,782,000 | 5.70% |
Samsara BioCapital, LLC | 3,168,388 | $44,738,000 | 5.52% |
FRAZIER MANAGEMENT LLC | 1,100,000 | $15,532,000 | 1.43% |
Altium Capital Management LP | 416,567 | $5,882,000 | 1.36% |
Affinity Asset Advisors, LLC | 200,000 | $2,824,000 | 1.01% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 170,821 | $2,412,000 | 0.64% |
Vivo Capital, LLC | 872,151 | $12,315,000 | 0.53% |
EcoR1 Capital, LLC | 931,650 | $13,155,000 | 0.49% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $17,452,000 | 0.31% |
Rubric Capital Management LP | 325,863 | $4,601,000 | 0.29% |